# EDGAR Filing Document

**Accession Number:** 0001133470
**File Stem:** 0001558370-25-011971
**Filing Date:** 2025-9
**Character Count:** 113691
**Document Hash:** 1593bd4ccb322829115ac83500516b02
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001558370-25-011971.hdr.sgml**: 20250909

**ACCESSION NUMBER**: 0001558370-25-011971

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 58

**CONFORMED PERIOD OF REPORT**: 20250731

**FILED AS OF DATE**: 20250909

**DATE AS OF CHANGE**: 20250909

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CALAVO GROWERS INC
- **CENTRAL INDEX KEY:** 0001133470
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE SERVICES [0700]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 330945304
- **STATE OF INCORPORATION:** CA
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-33385
- **FILM NUMBER:** 251304101

**BUSINESS ADDRESS:**
- **STREET 1:** 1141A CUMMINGS ROAD
- **CITY:** SANTA PAULA
- **STATE:** CA
- **ZIP:** 93060
- **BUSINESS PHONE:** 805-525-1245

**MAIL ADDRESS:**
- **STREET 1:** 1141A CUMMINGS ROAD
- **CITY:** SANTA PAULA
- **STATE:** CA
- **ZIP:** 93060

?xml version='1.0' encoding='ASCII'? CALAVO GROWERS, INC_July 31, 2025

[**Table of Contents**](#Toc)

------

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

### FORM 10-Q
**☒**  **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** 

#### For the quarterly period ended July 31, 2025
**or**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**☐** **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**For the transition period from ______________________ to ______________________**

**Commission File Number: 000-33385**

### CALAVO GROWERS, INC.
**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| **California** | **33-0945304** |
| (State or other jurisdiction of <br>incorporation or organization) | (I.R.S. Employer Identification No.) |

---

---

| | |
|:---|:---|
| **1141-A Cummings Road, Santa Paula, California**  | **93060** |
| (Address of principal executive offices) | (Zip Code) |

---

**(805) 525-1245**

(Registrant's telephone number, including area code)

**Not Applicable**

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, $0.001 par value per share | CVGW | Nasdaq Global Select Market |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp; Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | |
|:---|:---|
| Large accelerated filer ☐  | Accelerated filer ☒ |
| Non-accelerated filer ☐ | Smaller reporting company ☐ |
|  | Emerging growth company ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Registrant's number of shares of common stock outstanding as of August 31, 2025 was 17,853,323.

------

[**Table of Contents**](#Toc)

**FORWARD-LOOKING STATEMENTS**

This Quarterly Report on Form 10-Q, including "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Part I, Item 2, contains statements relating to future events and results of Calavo Growers, Inc. and its consolidated subsidiaries ("Calavo," the "Company," "we," "us" or "our") that are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and assumptions, are based on current expectations, and are not guarantees of future performance. If any of these risks or uncertainties materialize, or if underlying assumptions prove incorrect, actual results may differ materially from those expressed or implied in the forward-looking statements.

All statements other than historical facts are forward-looking statements, including but not limited to:

● Projections of revenue, gross profit, expenses, net sales, income/loss from unconsolidated entities, earnings per share, tax provisions, cash flows, and exchange rates;

● The impact of acquisitions, equity investments, or other financial transactions;

● Management's plans and objectives for future operations, including restructuring and integration efforts;

● Commentary on macroeconomic trends or global events and their potential impact on Calavo's performance;

● Updates on legal matters, investigations, or tax disputes;

● Statements regarding potential impacts of changes in U.S. and foreign trade policy, including tariffs and quotas, on our sourcing, costs, pricing, and demand;

● Statements regarding our cybersecurity risk management, planned enhancements to controls and documentation, and the potential impact of cyber incidents on operations, liquidity, or results;

● Statements regarding working capital and liquidity, including the timing and magnitude of tariff prepayments and the timing of VAT/IVA (as each such term is defined below) refund collections in Mexico;

● Statements regarding the timing and outcomes of legal and tax proceedings in Mexico, including the recovery of IVA receivables and the resolution of assessments by the Mexican Tax Administration Service ("SAT"), and the effects of related court rulings; and

● Statements regarding potential changes in Mexico's tax policies or enforcement actions and the expected effects on our operations, costs, tax positions, or liquidity.

The words "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "projects," and similar expressions often indicate forward-looking statements.

Factors that may cause actual results to differ materially from these forward-looking statements include, but are not limited to:

● Our ability to successfully execute operating and restructuring initiatives;

● The potential long-term effects of capital expenditure reductions;

● Adverse weather impacting supply and costs;

● Seasonal fluctuations;

● Volatility in avocado and raw material prices (including packaging, paper, and fuel);

● Risks related to enhanced regulatory scrutiny or inspection protocols, including detention holds by the U.S. Food and Drug Administration, which have resulted and could in the future result in shipment delays, incremental costs, or loss of product value;

● Supply chain disruptions;

● Risks from current or future acquisitions, including integration;

● Data breaches or cybersecurity incidents;

● Dependency on large customers and key personnel;

● Labor availability and wage inflation;

● Co-packer reliance and competitive pressures;

● Product recalls or food safety issues;

● Shifting consumer preferences and sustainability trends;

● Environmental regulations and climate-related supply risk;

● Global trade complexities, including restrictions, tariffs, and currency movements;

● Exposure to unconsolidated entities and the volatility of our stock; and

● The resolution of pending matters with the SAT and the risk of unfavorable legal or administrative outcomes.

Additional information about these and other risks is included in our most recent Annual Report on Form 10-K for the fiscal year ended October 31, 2024, and in our subsequent Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission.

Forward-looking statements are made as of the date of this report. We undertake no obligation to update or revise them, except as required by applicable securities laws.

[**Table of Contents**](#Toc)

**CALAVO GROWERS, INC.**

**INDEX**

---

| | | |
|:---|:---|:---|
|  |  | PAGE |
| [**PART I. FINANCIAL INFORMATION**](#PARTIFINANCIALINFORMATION_424709) | [**PART I. FINANCIAL INFORMATION**](#PARTIFINANCIALINFORMATION_424709) |  |
| [Item 1.](#ITEM1FINANCIALSTATEMENTS_622398) | [Financial Statements:](#ITEM1FINANCIALSTATEMENTS_622398) |  |
|  | [Condensed Consolidated Balance Sheets –July 31, 2025 and October 31, 2024 (Unaudited)](#BALANCESHEETS_471425) | 4 |
|  | [Condensed Consolidated Statements of Operations – Three and Nine Months Ended July 31, 2025 and 2024 (Unaudited)](#CONSOLIDATEDCONDENSEDSTATEMENTSOFOPERATI) | 5 |
|  | [Condensed Consolidated Statements of Cash Flows – Nine Months Ended July 31, 2025 and 2024 (Unaudited)](#CASHFLOWS_234996) | 6 |
|  | [Condensed Consolidated Statements of Shareholders' Equity – Three and Nine Months Ended July 31, 2025 and 2024 (Unaudited)](#EQUITY)  | 7 |
|  | [Notes to Condensed Consolidated Financial Statements (Unaudited)](#NOTESTOCONSOLIDATEDCONDENSEDFINANCIALSTA) | 8 |
| [Item 2.](#MANAGEMENTSDISCUSSION_952267) | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#MANAGEMENTSDISCUSSION_952267) | 19 |
| [Item 3.](#ITEM3_226172) | [Quantitative and Qualitative Disclosures About Market Risk](#ITEM3_226172) | 27 |
| [Item 4.](#ITEM4_419716) | [Controls and Procedures](#ITEM4_419716) | 27 |
| [**PART II. OTHER INFORMATION**](#PARTIIOTHERINFORMATION_891681) | [**PART II. OTHER INFORMATION**](#PARTIIOTHERINFORMATION_891681) |  |
| [Item 1.](#ITEM1LEGALPROCEEDINGS_316712) | [Legal Proceedings](#ITEM1LEGALPROCEEDINGS_316712) | 27 |
| [Item 1A.](#ITEM1ARISKFACTORS_393152) | [Risk Factors](#ITEM1ARISKFACTORS_393152) | 28 |
| [Item 5.](#ITEM5OTHERINFORMATION_190136) | [Other Information](#ITEM5OTHERINFORMATION_190136) | 29 |
| [Item 6.](#ITEM6EXHIBITS_479582) | [Exhibits](#ITEM6EXHIBITS_479582) | 29 |
|  | [Signatures](#SIGNATURES_984798) | 30 |

---

[**Table of Contents**](#Toc)

**PART I. FINANCIAL INFORMATION**

#### ITEM 1. FINANCIAL STATEMENTS
**CALAVO GROWERS, INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)** 

**(in thousands)**

---

| | | |
|:---|:---|:---|
|  | **July 31,** <br>**2025** | **October 31,** <br>**2024** |
| **Assets** |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $63754 | $57031 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net of allowances of $3,430 (2025) and $3,624 (2024)  | 41467 | 41909 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 30328 | 34157 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 8411 | 9976 |
| &nbsp;&nbsp;&nbsp;&nbsp;Advances to suppliers | 14216 | 14570 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes receivable | 936 | 936 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 159112 | 158579 |
| Property, plant, and equipment, net | 50603 | 54200 |
| Operating lease right-of-use assets | 16813 | 18316 |
| Investments in unconsolidated entities | 2602 | 2424 |
| Deferred income tax assets | 7473 | 7473 |
| Goodwill | 10211 | 10211 |
| Other assets | 54435 | 49916 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $301249 | $301119 |
| **Liabilities and shareholders' equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Payable to growers | $31849 | $18377 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade accounts payable | 9772 | 8742 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | 10459 | 28149 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax payable | 1721 | 2767 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | 11000 | 11000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of operating leases | 3479 | 3296 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of finance leases | 921 | 874 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 69201 | 73205 |
| Long-term liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term portion of operating leases | 15594 | 17476 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term portion of finance leases | 4211 | 4274 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other long-term liabilities | 4243 | 4388 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total long-term liabilities | 24048 | 26138 |
| Commitments and contingencies (Note 6) |  |  |
| Shareholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock ($0.001 par value, 100,000 shares authorized; 17,853 (2025) and 17,802 (2024) shares issued and outstanding) | 18 | 18 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 178803 | 177973 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 27603 | 22341 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Calavo Growers, Inc shareholders' equity | 206424 | 200332 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interest | 1576 | 1444 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 208000 | 201776 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $301249 | $301119 |

---

*The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.*

[**Table of Contents**](#Toc)

**CALAVO GROWERS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)**

**(in thousands, except per share amounts)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three months ended**  | **Three months ended**  | **Nine months ended**  | **Nine months ended**  |
|  | **July 31,**  | **July 31,**  | **July 31,**  | **July 31,**  |
|  | **2025** | **2024** | **2025** | **2024** |
| Net sales | $178822 | $179596 | $523753 | $491585 |
| Cost of sales | 160624 | 159503 | 471738 | 440071 |
| Gross profit | 18198 | 20093 | 52015 | 51514 |
| Selling, general and administrative | 9232 | 10510 | 29822 | 36993 |
| Expenses related to Mexican tax matters | 307 | 225 | 858 | 810 |
| Operating income | 8659 | 9358 | 21335 | 13711 |
| Foreign currency loss | (2483) | (4203) | (2488) | (2799) |
| Interest income | 879 | 100 | 2486 | 340 |
| Interest expense | (199) | (833) | (616) | (2619) |
| Other income, net | 89 | 81 | 814 | 561 |
| Income before income taxes and net income from unconsolidated entities | 6945 | 4503 | 21531 | 9194 |
| Income tax benefit (expense) | (1807) | 1441 | (5598) | 478 |
| Net income (loss) from unconsolidated entities | (402) | (579) | 178 | (374) |
| Net income from continuing operations | 4736 | 5365 | 16111 | 9298 |
| Net loss from discontinued operations (Note 10) |  | (6127) |  | (10218) |
| Net income (loss) | 4736 | (762) | 16111 | (920) |
| Less: Net loss (income) attributable to noncontrolling interest | (22) | 30 | (132) | (17) |
| Net income (loss) attributable to Calavo Growers, Inc. | $4714 | $(732) | $15979 | $(937) |
| Calavo Growers, Inc.'s net income (loss) per share: |  |  |  |  |
| Basic |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Continuing Operations | $0.26 | $0.30 | $0.90 | $0.52 |
| &nbsp;&nbsp;&nbsp;&nbsp;Discontinued Operations | $— | $(0.34) | $— | $(0.57) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to Calavo Growers, Inc | $0.26 | $(0.04) | $0.90 | $(0.05) |
| Diluted |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Continuing Operations | $0.26 | $0.30 | $0.89 | $0.52 |
| &nbsp;&nbsp;&nbsp;&nbsp;Discontinued Operations | $— | $(0.34) | $— | $(0.57) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to Calavo Growers, Inc | $0.26 | $(0.04) | $0.89 | $(0.05) |
| Number of shares used in per share computation: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 17853 | 17801 | 17842 | 17800 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 17899 | 17842 | 17893 | 17848 |

---

*The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.*

[**Table of Contents**](#Toc)

**CALAVO GROWERS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)**

**(in thousands)**

---

| | | |
|:---|:---|:---|
|  | **Nine months ended July 31,**  | **Nine months ended July 31,**  |
|  | **2025** | **2024** |
| **Cash Flows from Operating Activities:** |  |  |
| Net income (loss) | $16111 | $(920) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;Depreciation and amortization | 5656 | 8675 |
| &nbsp;&nbsp;Non-cash operating lease expense | (196) | (1739) |
| &nbsp;&nbsp;Net (income) loss from unconsolidated entities | (178) | 374 |
| &nbsp;&nbsp;Impairment of goodwill |  | 9280 |
| &nbsp;&nbsp;Provision for uncollectible Mexican IVA taxes receivable |  | 165 |
| &nbsp;&nbsp;Stock-based compensation expense | 878 | 1834 |
| &nbsp;&nbsp;Amortization of debt issuance costs | 137 |  |
| &nbsp;&nbsp;Gain on sale of Temecula packinghouse | (166) | (162) |
| &nbsp;&nbsp;&nbsp;&nbsp;(Gain) loss on disposal of property, plant, and equipment | (10) | 56 |
| Effect on cash of changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 442 | (17243) |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 3829 | 259 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 2165 | 3492 |
| &nbsp;&nbsp;&nbsp;&nbsp;Advances to suppliers | (246) | 2456 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes receivable/payable | (1046) | (2517) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | (4656) | (748) |
| &nbsp;&nbsp;&nbsp;&nbsp;Payable to growers | 13472 | 11588 |
| &nbsp;&nbsp;&nbsp;&nbsp;Trade accounts payable, accrued expenses and other liabilities | (16958) | (1267) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 19234 | 13583 |
| **Cash Flows from Investing Activities:** |  |  |
| Purchases of property, plant, and equipment | (1066) | (2519) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (1066) | (2519) |
| **Cash Flows from Financing Activities:** |  |  |
| Payment of dividend to shareholders | (10717) | (5341) |
| Proceeds from revolving credit facility |  | 95733 |
| Payments on revolving credit facility |  | (100838) |
| Payments of minimum withholding taxes on net share settlement of equity awards | (48) | (625) |
| Payments on term loan |  | (445) |
| Payments on long-term obligations and finance leases | (680) | (1274) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash (used in) financing activities | (11445) | (12790) |
| Net increase (decrease) in cash, cash equivalents | 6723 | (1726) |
| Cash, cash equivalents, beginning of period | 57031 | 2852 |
| Cash, cash equivalents, end of period | $63754 | $1126 |
| **Noncash Investing and Financing Activities:** |  |  |
| Right of use assets obtained in exchange for new financing lease obligations | $664 | $640 |
| Settlement of Agricola Belher infrastructure advance offset against payable to growers | $600 | $600 |
| Property, plant, and equipment included in trade accounts payable and accrued expenses | $319 | $29 |

---

*The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.*

[**Table of Contents**](#Toc)

**CALAVO GROWERS, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)**

**(in thousands)**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | | |
|  | **Shares** | **Amount** | **Additional**<br>**Paid-in**<br>**Capital** | <br>**Retained**<br>**Earnings** | <br>**Noncontrolling**<br>**Interest** | <br>**Total** |
| **Balance, April 30, 2025** | 17876 | $18 | $178522 | $26465 | $1554 | $206559 |
| Issuance of common stock in connection with stock-based compensation, net of tax withholdings | (23) |  |  |  |  |  |
| Stock-based compensation expense |  |  | 281 |  |  | 281 |
| Dividend declared to shareholders (0.20 per share) |  |  |  | (3576) |  | (3576) |
| Payment of min. withholding of taxes on net share settlement of equity awards |  |  |  |  |  |  |
| Avocados de Jalisco noncontrolling interest  |  |  |  |  | 22 | 22 |
| Net income attributable to Calavo Growers, Inc. |  |  |  | 4714 |  | 4714 |
| **Balance, July 31, 2025** | 17853 | $18 | $178803 | $27603 | $1576 | $208000 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | | |
|  | **Shares** | **Amount** | **Additional**<br>**Paid-in**<br>**Capital** | <br>**Retained**<br>**Earnings** | <br>**Noncontrolling**<br>**Interest**  | <br>**Total** |
| **Balance, April 30, 2024** | 17800 | 18 | 177302 | 28572 | 1439 | 207331 |
| Issuance of common stock in connection with stock-based compensation, net of tax withholdings | 2 |  |  |  |  |  |
| Stock compensation expense |  |  | 388 |  |  | 388 |
| Dividend declared to shareholders (0.10 per share) |  |  |  | (1780) |  | (1780) |
| Avocados de Jalisco noncontrolling interest  |  |  |  |  | (30) | (30) |
| Net loss attributable to Calavo Growers, Inc.  |  |  |  | (732) |  | (732) |
| **Balance, July 31, 2024** | 17802 | $18 | $177690 | $26060 | $1409 | $205177 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | | |
|  | **Shares** | **Amount** | **Additional**<br>**Paid-in**<br>**Capital** | <br>**Retained**<br>**Earnings** | <br>**Noncontrolling**<br>**Interest**  | <br>**Total** |
| **Balance, October 31, 2024** | 17802 | $18 | $177973 | $22341 | $1444 | $201776 |
| Issuance of common stock in connection with stock-based compensation, net of tax withholdings | 51 |  | (48) |  |  | (48) |
| Stock-based compensation expense |  |  | 878 |  |  | 878 |
| Dividend declared to shareholders (0.20 per share) |  |  |  | (10717) |  | (10717) |
| Payment of min. withholding of taxes on net share settlement of equity awards |  |  |  |  |  |  |
| Avocados de Jalisco noncontrolling interest |  |  |  |  | 132 | 132 |
| Net income attributable to Calavo Growers, Inc.  |  |  |  | 15979 |  | 15979 |
| **Balance, July 31, 2025** | 17853 | $18 | $178803 | $27603 | $1576 | $208000 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Common Stock** | **Common Stock** | | | | |
|  | **Shares** | **Amount** | **Additional**<br>**Paid-in**<br>**Capital** | <br>**Retained**<br>**Earnings** | <br>**Noncontrolling**<br>**Interest**  | <br>**Total** |
| **Balance, October 31, 2023** | 17761 | $18 | $176481 | $32338 | $1392 | $210229 |
| Issuance of common stock in connection with stock-based compensation, net of tax withholdings | 41 |  | (625) |  |  | (625) |
| Stock-based compensation expense |  |  | 1834 |  |  | 1834 |
| Dividend declared to shareholders (0.10 per share) |  |  |  | (5341) |  | (5341) |
| Avocados de Jalisco noncontrolling interest |  |  |  |  | 17 | 17 |
| Net loss attributable to Calavo Growers, Inc.  |  |  |  | (937) |  | (937) |
| **Balance, July 31, 2024** | 17802 | $18 | $177690 | $26060 | $1409 | $205177 |

---

*See accompanying notes to unaudited condensed consolidated financial statements.*

[**Table of Contents**](#Toc)

**CALAVO GROWERS, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**1. Description of the business**

***Business***

Calavo Growers, Inc. ("Calavo," the "Company," "we," "us," or "our") is a global leader in sourcing, packing and distribution of fresh avocados, tomatoes, papayas and processing of guacamole and other avocado products. Drawing on decades of expertise with fresh and prepared produce, we deliver a broad portfolio of products to retail grocers, club and mass-merchandise stores, foodservice operators, and wholesalers worldwide. We procure avocados from California, Mexico, and other key growing regions. Across our operating facilities, we (i) sort, pack, ripen, and ship avocados, tomatoes, and Hawaiian-grown papayas and (ii) process and package fresh and frozen guacamole. Our products are distributed both domestically and internationally.

In the first quarter of fiscal 2025, we renamed our "Grown" reportable segment to "Fresh" to better reflect its activities; the change did not affect the segment's composition, financial results, or internal performance metrics. We report results under two segments: Fresh and Prepared.

***Basis of Presentation***

The accompanying unaudited condensed consolidated financial statements (the "interim financial statements") have been prepared by the Company in accordance with accounting principles generally accepted in the United States and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission ("SEC"). Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, the accompanying interim financial statements contain all adjustments, consisting of adjustments of a normal recurring nature necessary to present fairly the Company's financial position, results of operations and cash flows. The results of operations for interim periods are not necessarily indicative of the results that may be expected for a full year. These statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended October 31, 2024.

***Recently Issued Accounting Standards***

In November 2024, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2024-03, "Disaggregation of Income Statement Expenses," which expands interim and annual requirements to include disclosure about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. The guidance will be effective for annual periods beginning after December 15, 2026, with either retrospective or prospective application. The ASU allows for early adoption of these requirements. The Company is currently evaluating the potential effect that this ASU will have on its financial statement disclosures.

In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740) - Improvements to Income Tax Disclosures". This ASU amends Accounting Standards Codification ("ASC") 740 to enhance the nature of disclosures for income taxes. Specifically, the ASU requires public business entities to disclose additional information in categories defined within the ASU within the reconciliation of the effective tax rate to the statutory rate for federal, state and foreign income taxes. Additionally, the ASU requires disclosure of taxes paid, net of refunds received, disaggregated by federal, state and foreign taxes. ASU 2023-09 is effective for years beginning after December 15, 2024 with early adoption permitted. The Company is currently evaluating the potential effect that this ASU will have on its financial statement disclosures.

[**Table of Contents**](#Toc)

In November 2023, the FASB issued ASU 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures," which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses. ASU 2023-07 is effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the potential effect that this ASU will have on its financial statement disclosures.

**2. Information regarding our operations in different segments** 

During the first quarter of fiscal 2025, we changed the name of our 'Grown' reportable segment to 'Fresh' to more accurately represent the segment's business activities. This change in title does not affect the segment's composition, financial results, or how we assess performance internally. We report our operations in two different business segments: Fresh and Prepared. The Fresh segment consists of fresh avocados, tomatoes and papayas. The Prepared segment comprises all our guacamole products sold at retail and food service as well as avocado pulp sold to foodservice. These two business segments are presented based on how information is used by our Chief Executive Officer to measure performance and allocate resources. Selling, general and administrative expenses, as well as other non-operating income/expense items, are evaluated by our Chief Executive Officer in the aggregate. We do not allocate assets, or specifically identify them, to our operating segments. The sales data in the following tables is presented in thousands:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three months ended July 31, 2025** | **Three months ended July 31, 2025** | **Three months ended July 31, 2025** | **Three months ended July 31, 2024** | **Three months ended July 31, 2024** | **Three months ended July 31, 2024** |
|  | **Fresh** | **Prepared** | **Total** | **Fresh** | **Prepared** | **Total** |
| Avocados | $147344 | $— | $147344 | $151814 | $— | $151814 |
| Tomatoes | 5846 |  | 5846 | 9874 |  | 9874 |
| Papayas | 3085 |  | 3085 | 2268 |  | 2268 |
| Other fresh income | 24 |  | 24 | 24 |  | 24 |
| Guacamole  |  | 24254 | 24254 |  | 18388 | 18388 |
| Total gross sales | 156299 | 24254 | 180553 | 163980 | 18388 | 182368 |
| Less: sales allowances | (448) | (1283) | (1731) | (762) | (2010) | (2772) |
| Net sales | $155851 | $22971 | $178822 | $163218 | $16378 | $179596 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Nine months ended July 31, 2025** | **Nine months ended July 31, 2025** | **Nine months ended July 31, 2025** | **Nine months ended July 31, 2024** | **Nine months ended July 31, 2024** | **Nine months ended July 31, 2024** |
|  | <br>**Fresh** | <br>**Prepared** | <br>**Total** | <br>**Fresh** | <br>**Prepared** | <br>**Total** |
| Avocados | $431864 | $— | $431864 | $387500 | $— | $387500 |
| Tomatoes | 30844 |  | 30844 | 49226 |  | 49226 |
| Papayas | 9209 |  | 9209 | 8200 |  | 8200 |
| Other fresh income | 64 |  | 64 | 72 |  | 72 |
| Guacamole |  | 57395 | 57395 |  | 54107 | 54107 |
| Total gross sales | 471981 | 57395 | 529376 | 444998 | 54107 | 499105 |
| Less sales allowances | (1674) | (3949) | (5623) | (1999) | (5521) | (7520) |
| Net sales | $470307 | $53446 | $523753 | $442999 | $48586 | $491585 |

---

[**Table of Contents**](#Toc)

---

| | | | |
|:---|:---|:---|:---|
|  | <br>**Fresh** | <br>**Prepared** | <br>**Total** |
|  | **(All amounts are presented in thousands)** | **(All amounts are presented in thousands)** | **(All amounts are presented in thousands)** |
| **Three months ended July 31, 2025** |  |  |  |
| Net sales | $155851 | $22971 | $178822 |
| Cost of sales | 143424 | 17200 | 160624 |
| Gross profit | $12427 | $5771 | $18198 |
| **Three months ended July 31, 2024** |  |  |  |
| Net sales | $163218 | $16378 | $179596 |
| Cost of sales | 145043 | 14460 | 159503 |
| Gross profit | $18175 | $1918 | $20093 |
|  | **Fresh** | **Prepared** | **Total** |
|  | **(All amounts are presented in thousands)** | **(All amounts are presented in thousands)** | **(All amounts are presented in thousands)** |
| **Nine months ended July 31, 2025** |  |  |  |
| Net sales | $470307 | $53446 | $523753 |
| Cost of sales | 431690 | 40048 | 471738 |
| Gross profit | $38617 | $13398 | $52015 |
| **Nine months ended July 31, 2024** |  |  |  |
| Net sales | $442999 | $48586 | $491585 |
| Cost of sales | 402041 | 38030 | 440071 |
| Gross profit | $40958 | $10556 | $51514 |

---

For the three months ended July 31, 2025, intercompany sales and cost of sales of $0.1 million between Fresh products and Prepared products were eliminated. For the nine months ended July 31, 2025 and 2024, intercompany sales and cost of sales of $0.8 million and $0.6 million between Fresh products and Prepared products were eliminated.

Sales to customers outside the U.S. were approximately $17.2 million and $11.9 million for the three months ended July 31, 2025, and 2024. Sales to customers outside the U.S. were approximately $42 million and $35.7 million for the nine months ended July 31, 2025 and 2024.

The net carrying value of long-lived assets attributed to geographic areas as of July 31, 2025, and October 31, 2024, are as follows (in thousands):

---

| | | | |
|:---|:---|:---|:---|
|  | **United States** | **Mexico** | **Consolidated** |
| July 31, 2025 | $22684 | $27919 | $50603 |
| October 31, 2024 | $24531 | $29669 | $54200 |

---

&nbsp;&nbsp;&nbsp;&nbsp;**3.** **Inventories** 

Inventories consist of the following (in thousands):

---

| | | |
|:---|:---|:---|
|  | **July 31,** <br>**2025** | **October 31,** <br>**2024** |
| Fresh fruit | $16233 | $20002 |
| Packing supplies and ingredients | 6932 | 6936 |
| Finished prepared foods | 7163 | 7219 |
| Total | $30328 | $34157 |

---

Inventories are stated at the lower of cost or net realizable value. We periodically review the value of items in inventory and record any necessary write downs of inventory based on our assessment of market conditions. Inventory includes reserves of $2.6 million in slow moving inventories and amounts estimated not to be sold as of July 31, 2025 and $0.4 million as of October 31, 2024. The increase in reserves at July 31, 2025 reflects higher slow-moving

[**Table of Contents**](#Toc)

inventories and market-related factors in the third quarter, including the temporary detention hold on certain avocados from Mexico by the U.S. Food and Drug Administration (the "FDA"), which led to inventory write-downs on fruit diverted or sold at distressed prices. See Note 6 for additional information regarding this temporary FDA detention hold and the impacts thereof.

&nbsp;&nbsp;&nbsp;&nbsp;**4.** **Related party transactions** 

*Board of Directors & Chief Executive Officer*

Certain members of our Board of Directors market California avocados through Calavo pursuant to marketing agreements substantially similar to the marketing agreements that we enter into with other growers. For the three and nine months ended July 31, 2025, the amount of avocados procured from entities owned or controlled by members of our Board of Directors was $2.7 million and $4.3 million. For the three and nine months ended July 31, 2024, the aggregate amount of avocados procured from entities owned or controlled by members of our Board of Directors was $1.9 million and $2.2 million. As of July 31, 2025, we had less than $0.1 million in outstanding payables to these Board members. We did not have any amounts payable to the entities owned or controlled by these Board members as of October 31, 2024.

For the three and nine months ended July 31, 2025, we procured $2.5 million and $6 million of avocados from entities affiliated with our Chief Executive Officer. For the three and nine months ended July 31, 2024, we procured $3.3 million and $4.7 million of avocados from entities affiliated with our Chief Executive Officer. As of July 31, 2025, we had $0.7 million in outstanding payables to entities affiliated with our Chief Executive Officer. There were no outstanding payables to entities affiliated with our Chief Executive Officer as of October 31, 2024.

*Agricola Don Memo, S.A. de C.V. ("Don Memo")*

Calavo and Agricola Belher ("Belher") each have an equal one-half ownership interest in Don Memo. Pursuant to a management service agreement, Belher, through its officers and employees, has day-to-day power and authority to manage the operations of Don Memo.

As of July 31, 2025, and October 31, 2024, we had investments of $2.6 million and $2.4 million, respectively, representing Calavo's 50% ownership in Don Memo, which was included as an investment in unconsolidated entities on our balance sheet. We make advances to Don Memo for operating purposes, provide additional advances as shipments are made during the season, and return the proceeds from tomato sales under our marketing program to Don Memo, net of our commission and aforementioned advances. For the three months ended July 31, 2025 and 2024, we advanced $1.6 million and $0 of preseason advances to Don Memo. For the nine months ended July 31, 2025 and 2024, we advanced $4.5 million and $4.5 million of preseason advances to Don Memo. As of July 31, 2025 and October 31, 2024, we had outstanding advances of $8.2 million and $7.7 million to Don Memo. In October 2020, we entered into an infrastructure loan agreement with Don Memo for up to $2.4 million secured by certain property and equipment of Don Memo. This infrastructure loan accrues interest at 7.25%. The total outstanding infrastructure loan balance both at July 31, 2025 and at October 31, 2024, was $1.6 million which is included in prepaids and other current assets. During the three months ended July 31, 2025 and 2024, we incurred $2.2 million and $3.3 million of cost of sales to Don Memo. During the nine months ended July 31, 2025 and 2024, we incurred $10.6 million and $10.6 million of cost of sales to Don Memo pursuant to our purchase consignment agreement.

*Belher*

We make advances to Belher for operating purposes, provide additional advances as shipments are made during the season, and return the proceeds from tomato sales under our marketing program to Belher, net of our commission and aforementioned advances. For the three months ended July 31, 2025, we advanced $3.8 million of preseason advances to Behler. For the nine months ended July 31, 2025, we advanced $3.9 million of preseason advances to Belher. For the three and nine months ended July 31, 2024, we advanced $2.5 million and $3.5 million of preseason advances to Belher. We had grower advances due from Belher totaling $4.3 million as of July 31, 2025 and $5.1 million as of October 31, 2024, which are recorded as advances to suppliers. In July 2021, we made a bridge loan of $3.5 million to Belher. This

[**Table of Contents**](#Toc)

loan is secured by certain farmland in Mexico and accrues interest at 10%. As part of this loan agreement, we can withhold payments on both the infrastructure advances and the bridge loan by netting these amounts against the grower payable due to Belher. As of July 31, 2025, the bridge loan balance of $0.5 million was recorded in prepaid expenses and other current assets. At October 31, 2024, the bridge loan balance was $1.1 million, consisting of $0.6 million in prepaid expenses and other current assets and $0.5 million in other assets. During the three months ended July 31, 2025 and 2024, we incurred $2.9 million and $4.1 million of cost of sales to Belher pursuant to our purchase consignment agreement. During the nine months ended July 31, 2025 and 2024, we incurred $16 million and $29.1 million of cost of sales to Belher pursuant to our purchase consignment agreement.

*Avocados de Jalisco, S.A.P.I. de C.V. ("Avocados de Jalisco")*

In August 2015, we entered into a Shareholder's Agreement with various Mexican partners and created Avocados de Jalisco. Avocados de Jalisco is a Mexican corporation created to engage in procuring, packing and selling avocados. As of July 31, 2025, this entity was approximately 83% owned by Calavo and was consolidated in our interim financial statements. Avocados de Jalisco built a packinghouse located in Jalisco, Mexico, which began operations in June of 2017. During the three months ended July 31, 2025 and 2024, we purchased approximately $1.2 million and $3.5 million of avocados from the partners of Avocado de Jalisco. During the nine months ended July 31, 2025 and 2024 we purchased approximately $3 million and $7.1 million of avocados from the partners of Avocados de Jalisco.

&nbsp;&nbsp;&nbsp;&nbsp;**5.** **Other assets** 

Other assets consist of the following (in thousands):

---

| | | |
|:---|:---|:---|
|  | **July 31,** <br>**2025** | **October 31,** <br>**2024** |
| Mexican IVA (i.e., value-added) taxes receivable, net (see Note 9) | $53854 | $48739 |
| Infrastructure advances |  | 467 |
| Other | 581 | 710 |
| Total | $54435 | $49916 |

---

&nbsp;&nbsp;&nbsp;&nbsp;**6.** **Other events** 

***Dividends***

On January 31, 2025, we paid a dividend of $0.20 per share, or an aggregate of $3.6 million, to shareholders of record on January 10, 2025. On April 29, 2025, we paid a dividend of $0.20 per share, or an aggregate of $3.6 million to shareholders of record on April 1, 2025. On July 28, 2025, we paid a dividend of $0.20 per share, or an aggregate of $3.6 million, to shareholders of record on June 30, 2025. The Board of Directors declared a quarterly cash dividend of $0.20 per share to be paid on October 31, 2025, to shareholders of record on September 30, 2025.

***Regulatory matters***

In July 2025, the FDA placed Calavo de México ("CDM"), our wholly owned subsidiary, on a Red List Detention Hold after trace levels of Imazalil (not approved for avocados) were detected in a single line item. All subsequent third-party tests were clean. During the third quarter of fiscal 2025, the hold resulted in third-party inspection and testing costs, incremental logistics/handling costs, and inventory write-downs on fruit diverted or sold at distressed prices, with an estimated incremental cost of approximately $4.2 million recorded in cost of sales. This FDA matter was fully resolved in September 2025.

During our fourth quarter of 2025, we submitted an insurance claim seeking recovery of costs associated with the FDA detention hold described above. The claim remains under review, and while we are pursuing recovery and believe it is achievable, as of the date of this report we have not yet obtained sufficient information to conclude that recovery of recognized losses is probable under applicable accounting guidance. Accordingly, no insurance receivable has been

[**Table of Contents**](#Toc)

recorded. We will recognize any recovery up to the amount of recognized losses when realization becomes probable, and will recognize any amounts in excess of recognized losses, if any, when realized.

***Litigation***

From time to time, we are involved in litigation arising in the ordinary course of our business that we do not believe will have a material impact on our financial position, results of operations, or cash flows.

***Compliance matters***

On September 2, 2025, the U.S. Department of Justice officially notified us that it has closed its Foreign Corrupt Practices Act ("FCPA") inquiry related to our operations in Mexico.

In July 2025, the One Big Beautiful Bill Act ("OBBBA") was enacted into law in the U.S. The OBBBA includes numerous provisions that affect corporate taxation, including changes to bonus depreciation, the expensing of domestic research costs, and modifications to certain U.S. international tax rules. The company has analyzed the impacts of the OBBBA and reflected them in the current period. These impacts do not have a material effect on the tax rate for the three and nine months ended July 31, 2025. The majority of the tax law changes will take effect in future years.

***Mexico tax audits***

We conduct business both domestically and internationally and, as a result, one or more of our subsidiaries files income tax returns in U.S. federal, U.S. state and certain foreign jurisdictions. Accordingly, in the normal course of business, we are subject to examination by tax authorities, primarily in Mexico and the United States.

**2013 Assessment**

In January 2017, CDM received preliminary observations from the Servicio de Administración Tributaria in Mexico (the "SAT") related to an audit for fiscal year 2013 outlining certain proposed adjustments primarily related to intercompany funding, deductions for services from certain vendors/suppliers and Value Added Taxes ("VAT"). We provided a written rebuttal to these preliminary observations during our third fiscal quarter of 2017.

In January 2018, the SAT's local office in Uruapan issued to CDM a final tax assessment (the "2013 Assessment") totaling approximately 2.6 billion Mexican pesos (which includes annual adjustments for inflation, and equals approximately $138.7 million USD at July 31, 2025) related to income tax, flat rate business tax, value added tax and fines, related to this fiscal 2013 tax audit. This amount has been adjusted for inflation as of July 31, 2025 to the amount of 3 billion Mexican pesos (approximately $160 million USD). Additionally, the tax authorities have determined that we owe our employees profit-sharing liability, totaling approximately 118 million Mexican pesos (approximately $6.3 million USD at July 31, 2025). In August 2018, we filed an Administrative Appeal on the 2013 Assessment, appealing our case to the SAT's central legal department in Michoacan.

On June 25, 2021, we became aware that the Administrative Appeal had been resolved by the SAT against CDM on March 12, 2021, and that we had allegedly failed to timely respond to and challenge the SAT's notification of such resolution, therefore rendering the 2013 Assessment as definitive. Consequently, the SAT placed liens on the fixed assets of CDM, with a net book value of approximately $26 million USD, and on bank accounts of CDM totaling approximately $1 million USD in order to guarantee the 2013 Assessment. Based on legal counsel from our tax advisory firm, we and our tax advisory firm have concluded that the March notification was not legally communicated.

[**Table of Contents**](#Toc)

On August 18, 2021, we filed an Administrative Reconsideration (the "Reconsideration") before the Central Legal Department of the SAT located in Mexico City, asserting that the resolution in March of the Administrative Appeal was wrongly concluded, in particular with respect to the following matters:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o Failure to recognize CDM as a "maquiladora";

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o Considering the Company to have a permanent establishment in Mexico;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o Including fruit purchase deposits transferred by the Company to CDM as taxable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o Application of 16% VAT tax to fruit purchase deposits; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;o Imposing double-taxation on the fruit purchase transactions.

On August 20, 2021 CDM filed a Nullity Trial (the "Nullity Trial") with the Federal Tax Court in Mexico, which among other things, strongly contends that the notifications made by the SAT to CDM and its designated advisors of the resolution of the Administrative Appeal in March 2021 were not legally communicated. In addition, the Nullity Trial asserts the same matters central to the Reconsideration, as described above, as wrongly concluded in the resolution of the Administrative Appeal.

On October 13, 2023, the Company filed an extension of the Nullity Trial filed on August 20, 2021, as a result of the response to the lawsuit filed by the tax authority, pointing out that the tax authority's resolution is unlawful due to improper substantiation and motivation, because of the following:

● The QR Code does not allow the Company to verify the veracity of the document, and

● The notification of the tax assessment was not sent to the phone number indicated by the Company, when the tax authority was obliged to do so, among others.

On November 14, 2023, the Federal Tax Court acknowledged the admission of the extension to the lawsuit. Additionally, in November 2024, the Administrative Reconsideration and related Injunction action were finalized. The tax authority determined that the filing of the Administrative Reconsideration was not legally viable, citing the existence of a concurrent legal remedy—the Nullity Trial. Furthermore, the SAT noted a presumption that the Nullity Trial was filed within the required timeframe, as evidenced by its admission by the Federal Tax Court.

These resolutions can be used as supervening evidence to support the arguments that the Nullity Petition should be admitted. The resolutions will contribute to demonstrate that the SAT considers that the Nullity Petition was filed on time. This is a statement made within a formal procedure that contradicts what the SAT had been arguing (within the reconsideration procedure).

While we continue to believe that the tax assessment for fiscal year 2013 is completely without merit, and that we will prevail on the Nullity Trial in the Tax Court, we also believe that it is in the best interest of CDM and the Company to settle the 2013 Assessment as quickly as possible. In accordance with our cumulative probability analysis on uncertain tax positions, settlements made by the SAT in other cases, the 2011 tax assessment reached by CDM with the Ministry of Finance and Administration of the government of the State of Michoacan, Mexico, and the value of CDM assets, we recorded a provision of $11 million, in the third quarter of fiscal year 2021, as a discrete item in Income Tax Provision. The provision includes estimated fines, interest and inflationary adjustments.

We believe that this provision remains appropriate as of July 31, 2025 based on our cumulative probability analysis. We incurred $0.3 million and $0.9 million of related professional fees for the three and nine months ended July 31, 2025 which have been recorded in Expenses related to Mexican Tax matters on the consolidated statements of operations.

***Lease contingency***

In conjunction with the sale of the Fresh Cut business on August 15, 2024, the Company assigned certain leases to the buyer. As a result of these lease assignments, the buyer is the primary obligor under the leases, with the Company secondarily liable as a guarantor. If the buyer fails to perform under a lease, the Company could be responsible for fulfilling any remaining lease obligation. The leases had a remaining average term of 5.3 years as of October 31, 2024,

[**Table of Contents**](#Toc)

with a maximum exposure of $32.0 million in undiscounted future minimum lease payments, plus $13.3 million in potential additional payments related to common area maintenance, taxes, insurance, and other obligations.

As of July 31, 2025, we had not experienced any changes related to this contingency, and there were no new developments affecting its likelihood or potential financial impact. We continue to assess this obligation, but do not believe it is probable that we will be required to fulfill any obligations under these leases.

&nbsp;&nbsp;&nbsp;&nbsp;**7.** **Noncontrolling interest** 

The following table reconciles shareholders' equity attributable to noncontrolling interest related to Avocados de Jalisco (in thousands):

---

| | | |
|:---|:---|:---|
| | **Three months ended July 31,** | **Three months ended July 31,** |
| <br>**Avocados de Jalisco noncontrolling interest** | **2025** | **2024** |
| Noncontrolling interest, beginning  | $1554 | $1439 |
| Net income (loss) attributable to noncontrolling interest of Avocados de Jalisco | 22 | (30) |
| Noncontrolling interest, ending | $1576 | $1409 |
|  | **Nine months ended July 31,** | **Nine months ended July 31,** |
| **Avocados de Jalisco noncontrolling interest** | **2025** | **2024** |
| Noncontrolling interest, beginning  | $1444 | $1392 |
| Net income attributable to noncontrolling interest of Avocados de Jalisco | 132 | 17 |
| Noncontrolling interest, ending | $1576 | $1409 |

---

&nbsp;&nbsp;&nbsp;&nbsp;**8.** **Earnings per share** 

Basic and diluted net income (loss) per share is calculated as follows (data in thousands, except per share data):

---

| | | |
|:---|:---|:---|
|  | **Three months ended July 31,** | **Three months ended July 31,** |
|  | **2025** | **2024** |
| **Numerator:** |  |  |
| Net income from continuing operations | $4736 | $5365 |
| Less: Net (income) loss attributable to noncontrolling interest | (22) | 30 |
| Net income from continuing operations attributable to Calavo Growers, Inc. | 4714 | 5395 |
| Net loss from discontinued operations (Note 10) |  | (6127) |
| Net income (loss) attributable to Calavo Growers, Inc. | $4714 | $(732) |
| **Denominator:** |  |  |
| Weighted average shares - Basic | 17853 | 17801 |
| Effect on dilutive securities – Restricted stock/units/options | 46 | 41 |
| Weighted average shares - Diluted | 17899 | 17842 |
| **Net income from continuing operations** |  |  |
| Basic | $0.26 | $0.30 |
| Diluted  | $0.26 | $0.30 |
| **Net loss from discontinued operations (Note 10)** |  |  |
| Basic | $— | $(0.34) |
| Diluted  | $— | $(0.34) |
| **Net income (loss) per share attributable to Calavo Growers, Inc:** |  |  |
| Basic | $0.26 | $(0.04) |
| Diluted  | $0.26 | $(0.04) |

---

[**Table of Contents**](#Toc)

---

| | | |
|:---|:---|:---|
|  | **Nine months ended July 31,** | **Nine months ended July 31,** |
|  | **2025** | **2024** |
| **Numerator:** |  |  |
| Net income from continuing operations | $16111 | $9298 |
| Less: Net income attributable to noncontrolling interest | (132) | (17) |
| Net income from continuing operations attributable to Calavo Growers, Inc. | 15979 | 9281 |
| Net loss from discontinued operations (Note 10) |  | (10218) |
| Net income (loss) attributable to Calavo Growers, Inc. | $15979 | $(937) |
| **Denominator:** |  |  |
| Weighted average shares - Basic | 17842 | 17800 |
| Effect on dilutive securities – Restricted stock/units/options  | 51 | 48 |
| Weighted average shares - Diluted | 17893 | 17848 |
| **Net income from continuing operations** |  |  |
| Basic | $0.90 | $0.52 |
| Diluted  | $0.89 | $0.52 |
| **Net loss from discontinued operations (Note 10)** |  |  |
| Basic | $— | $(0.57) |
| Diluted  | $— | $(0.57) |
| **Net income (loss) per share attributable to Calavo Growers, Inc:** |  |  |
| Basic | $0.90 | $(0.05) |
| Diluted | $0.89 | $(0.05) |

---

&nbsp;&nbsp;&nbsp;&nbsp;**9.** **Mexican IVA taxes receivable** 

Included in other assets are tax receivables due from the Mexican government for value-added taxes ("IVA") paid in advance. CDM is charged IVA by vendors on certain expenditures in Mexico, which, insofar as they relate to the exportation of goods, translate into VAT amounts recoverable from the Mexican government.

As of July 31, 2025 and October 31, 2024, CDM VAT receivables, net of our estimated provision for uncollectable amounts, totaled $53.9 million (1.0 billion Mexican pesos) and $48.7 million (976.0 million Mexican pesos). Historically, CDM received VAT refund payments from the Mexican tax authorities on a timely basis. Beginning in fiscal 2014 and continuing into fiscal 2025, the tax authorities began objecting to refund requests and supporting documentation that had previously been deemed acceptable to process a refund. Additionally, they are also contesting the refunds requested attributable to VAT paid to certain suppliers that allegedly did not fulfill their own tax obligations. We believe these factors and others have contributed to delays in the processing of VAT claims by the Mexican tax authorities. Currently, we are in the process of collecting such balances primarily through regular administrative processes, but these amounts may ultimately need to be recovered through Administrative Appeals and/or other legal means.

During the first quarter of fiscal 2017, the tax authorities informed us that their internal opinion, based on the information provided by the local SAT office, considers that CDM was not properly documented relative to its declared tax structure and therefore CDM could not claim the refundable VAT balance. CDM has strong arguments and supporting documentation to sustain its declared tax structure for VAT and income tax purposes. CDM started an Administrative Appeal for the VAT related to the refund requests for the months of July, August and September of 2015 (the "2015 Appeal") in order to assert its argument that CDM is properly documented and to therefore change the SAT's

[**Table of Contents**](#Toc)

internal assessment. In August 2018, we received a favorable ruling from the SAT's Legal Administration in Michoacan on the 2015 Appeal indicating that they believe CDM's legal interpretation of its declared tax structure is indeed accurate. While favorable on this central matter of CDM's declared tax structure, the ruling, however, still does not recognize the taxpayer's right to a full refund for the VAT related to the months of July, August and September 2015. Therefore, in October 2018, CDM filed a substance-over-form Annulment Suit in the Federal Tax Court to recover its full refund for VAT over the subject period.

In April 2022, the Chamber specializing in exclusive resolution of the substantial matters belonging to the Federal Tax Court issued the ruling for the months of July, August and September 2015 through which it was declared that the following resolutions were resolved:

● It is recognized that CDM operates as a maquila under the authorization of the Ministry of Finance.

● It is recognized that all bank deposits corresponding to the purchase of avocados on behalf of Calavo are subject to the maquila program and it is not accruable income for purposes of Income Tax nor activities subject to VAT.

● It is recognized that VAT is recoverable, since CDM demonstrated the existence of operations carried under the maquila services.

● It is resolved that certain VAT amounts attributed to the purchase of certain packing materials are not recoverable as CDM was not the buyer on record and therefore did not pay for the materials, which approximated 6.9 million Mexican pesos (approximately $0.4 million USD).

We believe that our operations in Mexico are properly documented, and our internationally recognized tax advisors believe that there are legal grounds to prevail in collecting the corresponding VAT amounts. With assistance from our internationally recognized tax advisory firm, as of July 31, 2025, CDM filed Administrative Appeals for months for which VAT refunds have been denied by the SAT, and will continue filing such appeals for any months for which refunds are denied in the future. Therefore, we believe it is probable that the Mexican tax authorities will ultimately authorize the refund of the remaining VAT amounts.

During the second quarter of fiscal 2025, the SAT refunded 36.7 million Mexican pesos in VAT (approximately $1.9 million USD), including inflationary adjustments, relating to claims for March, April, and November 2019. These refunds were secured directly from the tax authority rather than through the court system.

*Recent legal development*

In August 2025, the Fifth Collegiate Circuit Court issued a ruling recognizing CDM as a maquila and directing the SAT to refund IVA balances for January through June 2013. We believe this decision provides important judicial confirmation of CDM's maquila status, which strengthens our position to recover outstanding IVA receivables and also reinforces our defense in the 2013 Assessment described in Note 6. In August 2025, the SAT appealed this decision to the Mexican Supreme Court. We will continue to pursue collection of IVA refunds through administrative processes and, where necessary, legal remedies.

**10.** **Assets Held for Sale and Discontinued Operations**

In August 2024, we completed the sale of our Fresh Cut business and related real estate for $83 million. The Fresh Cut business represented substantially all the Prepared segment, excluding the retained guacamole business.

As previously disclosed, the Fresh Cut business was classified as held for sale and discontinued operations in the first quarter of fiscal 2024. In connection with the sale, we recorded a $9.3 million goodwill impairment charge in the quarter ended July 31, 2024, based on the transaction's sale price.

[**Table of Contents**](#Toc)

The following table summarizes the results of operations of the Fresh Cut business that are being reported as discontinued operations (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Three months ended**<br>**July 31,** | **Nine months ended**<br>**July 31,**  |
|  | **2024** | **2024** |
| Net sales | $88586 | $258958 |
| Cost of sales | 81224 | 246955 |
| Gross profit  | 7362 | 12003 |
| Selling, general and administrative | 4193 | 12896 |
| Impairment of goodwill | 9280 | 9280 |
| Operating loss | (6111) | (10173) |
| Interest expense | (23) | (77) |
| Other income, net | 7 | 32 |
| Loss from discontinued operations before income taxes and gain on sale | (6127) | (10218) |
| Income tax benefit |  |  |
| Net loss from discontinued operations | $(6127) | $(10218) |

---

Select cash flow information related to the Fresh Cut business follows (in thousands):

---

| | |
|:---|:---|
|  | **Nine months ended**<br>**July 31,**  |
|  | **2024** |
| Net cash used in operating activities | $(7071) |
| Net cash used in investing activities | $(355) |

---

**11.** **Sale of Fresh Cut Business**

*Fresh Cut Business -- Asset Purchase Agreement and Purchase and Sale Agreement*

On August 15, 2024, we completed the sale of our Fresh Cut business and related real estate for a total transaction value of $83 million. The sale included certain assets, leasehold interests, and specified liabilities related to the Fresh Cut business, while the guacamole business was retained.

The purchase price for the business assets was $52.0 million, subject to customary adjustments, and the real estate was sold separately for $31.0 million. See Note 6.

*Amendment to Credit Agreement*

On August 15, 2024, we entered into a First Amendment to Credit Agreement and Consent (as amended, the "Credit Agreement") with Wells Fargo Bank, National Association, as agent and lender ("Agent"), whereby (i) the Credit Agreement was amended to reduce the revolving commitments thereunder from $90,000,000 to $75,000,000, among other minor adjustments to align the borrowing base with our current asset base excluding the Fresh Cut business (which was sold on August 15, 2024), and (ii) we obtained consent from Agent for entry into the Asset Purchase Agreement and Purchase and Sale Agreement with respect to the sale of the Fresh Cut business.

**12. Subsequent Events**

We have evaluated subsequent events through September 9, 2025, the date these interim financial statements were issued.

In August 2025, the Fifth Collegiate Circuit Court issued a ruling recognizing CDM as a maquila and directing the SAT to refund IVA balances for January through June 2013, as further described in Note 9.

[**Table of Contents**](#Toc)

The Board of Directors declared a quarterly cash dividend of $0.20 per share to be paid on October 31, 2025, to shareholders of record on September 30, 2025.

We have determined that, other than the ruling of the Fifth Collegiate Circuit Court and the dividend declaration noted above, no other material subsequent events have occurred that would require disclosure or adjustment to these interim financial statements.

**ITEM 2.** **MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS** 

This information should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto (the "interim financial statements") included in this Quarterly Report, and the audited consolidated financial statements and notes thereto and Management's Discussion and Analysis of Financial Condition and Results of Operations contained in the Annual Report on Form 10-K for the fiscal year ended October 31, 2024 of Calavo Growers, Inc. ("we", "Calavo", or the "Company").

***Recent Developments***

*Dividends*

On July 28, 2025, we paid a dividend of $0.20 per share, or an aggregate of $3.6 million to shareholders of record as of June 30, 2025. The Board of Directors declared a quarterly cash dividend of $0.20 per share to be paid on October 31, 2025, to shareholders of record on September 30, 2025.

*Compliance Matters*

On September 2, 2025, the U.S. Department of Justice officially notified us that it has closed its Foreign Corrupt Practices Act ("FCPA") inquiry related to our operations in Mexico.

From time to time, we are involved in litigation arising in the ordinary course of our business that we do not believe will have a material impact on our financial position, results of operations, or cash flows.

*Mexican Tax Issues*

During the second quarter of fiscal 2025, the SAT refunded 36.7 million Mexican pesos in VAT (approximately $1.9 million USD), including inflationary adjustments, relating to refund claims for March, April, and November 2019. These refunds were secured directly from the tax authority rather than through the court system and provide positive momentum as we continue working to recover additional outstanding balances. Management views these outcomes as a sign of progress in our broader tax strategy and of improved engagement with the SAT.

In August 2025, the Fifth Collegiate Circuit Court issued a ruling recognizing Calavo de México ("CDM") as a maquila and directing the SAT to refund IVA balances for January through June 2013. Management believes this decision provides important judicial confirmation of CDM's maquila status, strengthens our position to recover outstanding IVA receivables, and bolsters our defense in the 2013 Assessment described in Note 6 to the consolidated financial statements. In August 2025, the SAT appealed this decision to the Mexican Supreme Court. We will continue to pursue collection of IVA refunds through administrative processes and, where necessary, legal remedies.

*Market Trends and Uncertainties*

We continue to be impacted by macroeconomic challenges, including inflationary pressures and shifts in trade policies, which have affected our operations in the past and may continue to do so in the future. These challenges drive cost fluctuations in key areas such as fruit procurement, labor, corrugated and plastic packaging, and overall operating expenses. To manage these pressures, we implement various strategies, including adjusting selling prices and optimizing

[**Table of Contents**](#Toc)

global sourcing strategies. We anticipate that inflationary and other cost pressures will persist in the remainder of fiscal 2025 and there is no assurance that we will be able to fully offset these cost increases.

In July 2025, the U.S. Food and Drug Administration (the "FDA") placed our CDM facility on a detention hold after trace levels of Imazalil were detected in a single shipment of conventional avocados. All subsequent third-party tests were clean, and the hold was lifted in September 2025. While this was the first such event in our Mexican operations since they began in 1998, the detention hold caused incremental third-party inspection and testing costs, incremental logistics/handling costs, and inventory write-downs on fruit diverted or sold at distressed prices. Regulatory actions of this type, if repeated, could continue to disrupt our supply chain, increase costs, and adversely impact our operating results.

During our fourth quarter of 2025, we submitted an insurance claim seeking recovery of costs associated with the FDA detention hold described above. The claim remains under review, and while we are pursuing recovery and believe it is achievable, as of the date of this report we have not yet obtained sufficient information to conclude that recovery of recognized losses is probable under applicable accounting guidance. Accordingly, no insurance receivable has been recorded. We will recognize any recovery up to the amount of recognized losses when realization becomes probable, and will recognize any amounts in excess of recognized losses, if any, when realized.

In addition, ongoing uncertainty surrounding U.S. trade policy—particularly as it relates to Mexico—could adversely affect our business. On February 2, 2025, the United States announced tariffs of up to 25 percent on imports from several countries (including Mexico and Canada) and higher duties on selected Chinese goods; all of these measures were subsequently put on hold. A separate 25 percent tariff on Mexican imports was briefly in effect from March 4 to March 6, 2025, before being suspended. As of May 30, 2025, no further reciprocal tariffs are scheduled, but the situation remains fluid and additional trade actions could be announced without advance notice.

At present, it remains uncertain whether, and to what extent, any of the proposed tariffs or duties will apply to the fresh fruit and prepared products we import from Mexico. Given that a substantial portion of our produce originates there, new or increased trade barriers could raise our input costs. If we cannot pass along these extra costs to customers, renegotiate grower pricing, alter sourcing patterns, or implement other mitigation strategies, then our margins, operating results, and cash flows could be materially adversely affected.

Although tariffs on imports from Mexico introduce additional costs, we do not currently expect them to have a material impact on our long-term profitability. Given the evolving nature of trade policies and recent short-term financial impacts, we will continue to assess the situation, adjust our sourcing and pricing strategies as needed, and take proactive measures to mitigate potential challenges.

The U.S. Department of Commerce also terminated the U.S.–Mexico Tomato Suspension Agreement ("TSA") on July 14, 2025. Such termination automatically imposes a 17 percent anti-dumping duty on Mexican tomatoes. Industry groups such as the Texas International Produce Association warned that ending the TSA could sharply raise tomato prices, disrupt national supply chains, and threaten roughly 46,900 U.S. jobs tied to $3.1 billion in annual Mexican tomato imports. Because we source and distribute significant volumes of tomatoes, any resulting supply shortages or cost increases could materially adversely affect our sales volumes and customer relationships.

For additional information, see the risk factor entitled "Tariffs on Imported Goods Could Materially Impact Our Business, Financial Condition, and Results of Operations" in Part II, Item 1A. Risk Factors, in our Quarterly Report on Form 10-Q filed on March 12, 2025.

*Supply Chain Disruptions*

During our first fiscal quarter of 2025, one of our Mexican packinghouses temporarily paused its operations due to the detection of a small number of avocado weevils in a pre-production area. After completing remedial measures, including those described below, the affected packinghouse was re-certified by the relevant authorities and resumed

[**Table of Contents**](#Toc)

normal operations. During our second fiscal quarter of 2025, we implemented enhanced monitoring protocols in our pre-production areas, which have effectively prevented any further avocado weevil outbreaks. A severe outbreak of the avocado weevil in the future, however, could result in reduced avocado supply and higher procurement costs, impacting our ability to meet consumer demand and maintain product quality standards. Any sustained disruption caused by this pest could materially and adversely affect our business, financial condition, and results of operations.

Regulatory responses, such as quarantine measures or restrictions on avocado imports from affected regions, could further disrupt our supply chain, limit our sourcing options, and reduce the volume of avocados available for sale. The implementation of such measures, whether in response to pests or other phytosanitary or chemical compliance issues, may also continue to increase logistical complexities, delay shipments, and introduce additional compliance costs.

For additional information, see the risk factor entitled "The Spread of the Avocado Seed Weevil Could Disrupt Our Supply Chain and Adversely Impact Our Business" in Part II, Item 1A. Risk Factors, in our Quarterly Report on Form 10-Q filed on March 12, 2025.

**Critical Accounting Estimates** 

In preparing our financial statements in accordance with GAAP, we are required to make estimates and assumptions that affect the amounts of assets, liabilities, revenue, and costs and expenses that are reported in the financial statements and accompanying disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Our actual results may differ from these estimates and assumptions. To the extent that there are differences between our estimates and actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected.

There have been no material changes in our critical accounting estimates during the three and nine months ended July 31, 2025, as compared to those disclosed in the "Management's Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates" in our Annual Report on Form 10-K for our fiscal year ended October 31, 2024.

***Results of Operations***

***Net Sales***

The following table summarizes our net sales by business segment for each of the three and nine months ended July 31, 2025 and 2024 (dollar amounts in thousands):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three months ended July 31,**  | **Three months ended July 31,**  | **Three months ended July 31,**  | **Nine months ended July 31,**  | **Nine months ended July 31,**  | **Nine months ended July 31,**  |
|  | **2025** | **Change** | **2024** | **2025** | **Change** | **2024** |
| Net sales: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fresh | $155851 | (5)% | $163218 | $470307 | 6% | $442999 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepared | 22971 | 40% | 16378 | 53446 | 10% | 48586 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net sales | $178822 | (0)% | $179596 | $523753 | 7% | $491585 |
| &nbsp;&nbsp;As a percentage of sales: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fresh | 87% |  | 91% | 90% |  | 90% |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepared | 13% |  | 9% | 10% |  | 10% |
|  | 100.0% |  | 100.0% | 100.0% |  | 100.0% |

---

*Summary*

Net sales for the three months ended July 31, 2025, decreased by $0.8 million, or less than 1%, compared to the same period in fiscal 2024, reaching $178.8 million. This stability was driven primarily by a 2% increase in price per avocado

[**Table of Contents**](#Toc)

carton, partially offset by a 5% decrease in avocado carton volume, while Prepared segment sales increased by 40% year-over-year due primarily to increased sales volumes. Net sales for the nine months ended July 31, 2025, compared to the corresponding period in fiscal 2024, increased by $32.2 million, or approximately 7%. This growth was driven by a 6% increase in Fresh segment sales, primarily due to higher avocado pricing, partially offset by a decline in carton volume, while Prepared segment sales increased by 10% year-over-year due primarily to increases in sales volumes, while average selling prices remained steady.

We remain focused on expanding grower partnerships and strengthening relationships with retail and foodservice customers to support long-term net sales growth across both segments. Our Fresh and Prepared businesses are subject to seasonal trends, which may impact the volume and quality of raw materials sourced in any given quarter.

*Fresh products*

Third Quarter 2025 vs. Third Quarter 2024

Net sales for the Fresh segment decreased by approximately $7.4 million, or 5%, for the third quarter of fiscal 2025 compared to the same period in fiscal 2024. The decrease was primarily driven by lower avocado sales.

● Avocado sales decreased by $4.3 million, or 3%, due to a 5% decline in carton volume, partially offset by a 2% increase in average selling price per carton. While average prices were higher year over year, sales were negatively impacted by a sharp sequential decline from the second quarter to the third quarter as industry supply from Mexico, California, and Peru converged at elevated levels. The period-over-period volume decline also reflects sourcing shifts by certain large retailers during the quarter.

● Tomato sales decreased by $3.8 million, or 40%, primarily due to a 27% decline in carton volume and a 18% decrease in average selling price. The decline was primarily driven by the United States' termination of the 2019 Tomato Suspension Agreement on July 14, 2025, which resulted in the imposition of an approximate 17% anti-dumping duty on most fresh tomatoes imported from Mexico.

Nine Months Ended July 31, 2025 vs. Nine Months Ended July 31, 2024

Net sales for the Fresh segment increased by approximately $27.3 million, or 6%, for the nine months ended July 31, 2025, compared to the corresponding period in fiscal 2024. The increase was primarily due to higher average avocado selling prices, partially offset by a decline in avocado and tomato sales.

● Sales of avocados increased $44.6 million, or 12%, for the nine-month period, driven primarily by a 22% increase in average selling price per carton, partially offset by a 9% decline in volume. The majority of the volume decline occurred during the second quarter, though sequentially lower prices in the third quarter also reduced sales growth compared to the first half of fiscal 2025.

● Sales of tomatoes decreased $18.3 million, or 37%, primarily due to a 34% decline in volume and a 6% decrease in average selling price per carton. The decline was concentrated in the second and third quarters, reflecting adverse weather and abundant domestic supply that reduced import demand in the third quarter of fiscal 2025.

*Prepared products*

Third Quarter 2025 vs. Third Quarter 2024

Net sales for the Prepared segment increased by $6.6 million, or 40%, for the three months ended July 31, 2025, compared to the same period in fiscal 2024. The increase was primarily driven by a 35% increase in pounds sold and a 3% increase in average selling price per pound. Growth reflected expanded sales to existing customers and meaningful new customer wins across retail and foodservice in both domestic and international markets. Net sales also benefited from an updated estimate of sales allowances, which increased revenue by approximately $0.5 million based on recent

[**Table of Contents**](#Toc)

claims experience and customer mix. Our avocado squeeze pouch product contributed modestly to the quarter, supported by its extended shelf life and portion control format.

Nine Months Ended July 31, 2025 vs. Nine Months Ended July 31, 2024

Net sales for the Prepared segment increased by $4.9 million, or 10%, for the nine months ended July 31, 2025, compared to the same period in fiscal 2024. The increase was primarily due to an 11% increase in pounds sold, partially offset by a 1% decrease in average selling price per pound. In the third quarter, strong volume growth and customer program expansion more than offset earlier softness, with momentum driven by expanded sales to existing customers, new wins across retail and foodservice in both domestic and international markets, modestly higher pricing on certain products, lower fruit input costs, and improved operating efficiencies. Our avocado squeeze pouch product also contributed modestly to year-to-date growth. Based on recent trends, including the third-quarter ramp, we currently estimate Prepared segment sales of approximately $115 million in fiscal 2026, subject to demand, pricing, and execution.

***Gross Profit***

The following table summarizes our gross profit and gross profit percentages by business segment for the three and nine months ended July 31, 2025, and 2024 (dollar amounts in thousands):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three months ended July 31,**  | **Three months ended July 31,**  | **Three months ended July 31,**  | **Nine months ended July 31,**  | **Nine months ended July 31,**  | **Nine months ended July 31,**  |
|  | **2025** | **Change** | **2024** | **2025** | **Change** | **2024** |
| Gross profit: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fresh | $12427 | (32)% | $18175 | $38617 | (6)% | $40958 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepared | 5771 | 201% | 1918 | 13398 | 27% | 10556 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total gross profit | $18198 | (9)% | $20093 | $52015 | 1% | $51514 |
| &nbsp;&nbsp;Gross profit percentages: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Fresh | 8% |  | 11% | 8% |  | 9% |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepared | 25% |  | 12% | 25% |  | 22% |
| &nbsp;&nbsp;&nbsp;&nbsp;Consolidated | 10% |  | 11% | 10% |  | 10% |

---

*Summary*

Our cost of goods sold consists primarily of ingredient costs (including fruit and other food products), packing materials, freight and handling, labor, and overhead (including depreciation) associated with packing, distributing, and/or preparing food products, as well as other direct expenses related to products sold.

Gross profit decreased by approximately $1.9 million, or 9%, for the third quarter of fiscal 2025, compared to the corresponding period in fiscal 2024. The decline was primarily driven by approximately $4.2 million of discrete costs associated with the FDA detention hold on certain avocado imports from Mexico, where the fungicide was present on fruit purchased from a grower and is never applied in Calavo facilities, as well as lower volumes and pricing pressure in tomatoes due to abundant U.S. supply that reduced import demand.

Gross profit increased by $0.5 million, or 1%, for the nine months ended July 31, 2025, compared to the same period in fiscal 2024. Prepared segment gross profit rose by $2.8 million, or 27%, driven by an 11% increase in pounds sold, continued operating leverage, and lower fruit input costs. This improvement offset a $2.3 million, or 6%, decline in Fresh segment gross profit, which reflected lower avocado and tomato volumes and included approximately $4.2 million of discrete costs associated with the FDA detention hold on certain avocado imports from Mexico in the third quarter.

[**Table of Contents**](#Toc)

*Fresh products*

The decrease in Fresh products gross profit for the third quarter of fiscal 2025 was primarily driven by lower volumes for both avocados and tomatoes.

● Avocado gross profit decreased, reflecting lower carton volumes and the impact of approximately $4.2 million of discrete costs associated with the FDA detention hold on certain avocado imports from Mexico in July 2025. The detention hold resulted in third-party inspection and testing costs, incremental logistics/handling costs, and inventory write-downs on fruit diverted or sold at distressed prices, which reduced per-carton profitability despite higher average selling prices year-over-year.

● Tomato gross profit decreased, driven by a 27% decline in carton volume and lower average selling prices. Market conditions in the U.S. remained oversupplied during the quarter, which reduced demand for Mexican imports and pressured pricing.

The decrease in Fresh products gross profit for the nine months ended July 31, 2025, was primarily driven by lower avocado and tomato volumes along with regulatory costs such as third-party inspection and testing costs, incremental logistics/handling costs, and inventory write-downs on fruit diverted or sold at distressed prices related, to the FDA detention hold in the third quarter and a temporary tariff event in the second quarter.

● Avocado gross profit decreased by $1.5 million, reflecting lower carton volumes and reduced per-carton profitability. Profitability was negatively impacted by the three-day tariff event described in our Quarterly Report on Form 10-Q for our fiscal quarter ended April 30, 2025 and by the costs associated with the FDA detention hold on certain avocado imports from Mexico in the third quarter.

● Tomato gross profit decreased by $0.8 million, reflecting lower volume and modestly reduced average selling prices. The decline was concentrated in the second and third quarters: in the second quarter, adverse winter weather in key U.S. markets and strong domestic supply led to sales at or near contractual pricing floors and underutilization of fixed cost infrastructure; and in the third quarter, abundant domestic supply continued to limit import opportunities and weigh on pricing.

*Prepared products*

Gross profit per pound for guacamole products increased during the third quarter of fiscal 2025 compared to the same period last year, reflecting improved operational efficiency and stronger cost management. For the nine months ended July 31, 2025, Prepared segment gross profit increased 14.6% to $13.4 million, reflecting higher sales volumes, lower fruit input costs compared to the prior year, and improved operating efficiencies.

***Selling, General and Administrative***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three months ended July 31,**  | **Three months ended July 31,**  | **Three months ended July 31,**  | **Nine months ended July 31,**  | **Nine months ended July 31,**  | **Nine months ended July 31,**  |
|  | **2025** | **Change** | **2024** | **2025** | **Change** | **2024** |
|  | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| Selling, general and administrative | $9232 | (12)% | $10510 | $29822 | (19)% | $36993 |
| Percentage of net sales | 5% |  | 6% | 6% |  | 8% |

---

Selling, general, and administrative (SG&A) expenses totaled $9.2 million for the three months ended July 31, 2025. These expenses include marketing and advertising costs, sales expenses (including broker commissions), and other general and administrative costs.

SG&A expenses for the three months ended July 31, 2025 decreased by $1.3 million, or 12%, compared to the three months ended July 31, 2024. The decrease was driven by a $2.0 million reduction in professional and consulting fees, including lower FCPA-related legal expenses, partially offset by a $0.3 million increase in bonus expense.

[**Table of Contents**](#Toc)

SG&A expenses for the nine months ended July 31, 2025 decreased by $7.2 million, or 19%, compared to the prior year period. The decrease was driven by a $5.1 million reduction in professional and consulting fees, primarily related to lower legal costs (including reduced FCPA investigation-related legal expenses), a $1.7 million reduction in compensation expenses reflecting lower headcount and severance costs, and a $0.8 million decrease in stock-based compensation, mainly related to the Chief Executive Officer's compensation structure.

***Foreign currency loss***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three months ended July 31,**  | **Three months ended July 31,**  | **Three months ended July 31,**  | **Nine months ended July 31,** | **Nine months ended July 31,** | **Nine months ended July 31,** |
|  | **2025** | **Change** | **2024** | **2025** | **Change** | **2024** |
|  | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| Foreign currency loss | $(2483) | (41)% | $(4203) | $(2488) | (11)% | $(2799) |

---

Our foreign operations in Mexico are subject to exchange rate fluctuations and foreign currency transaction costs. The functional currency of our foreign subsidiaries in Mexico is the United States dollar (U.S. dollar). As a result, monetary assets and liabilities are remeasured into U.S. dollars at exchange rates as of the balance sheet date and non-monetary assets, liabilities and equity are remeasured at historical rates. Sales and expenses are remeasured using a weighted-average exchange rate for the period.

Due to the change in the Mexican peso to the U.S. dollar exchange rates, foreign currency remeasurement losses, net of gains, for the three and nine months ended July 31, 2025, were $2.5 million. Net foreign currency remeasurement (losses), for the three and nine months ended July 31, 2024, were $(4.2) million and $(2.8) million.

***Income (loss) from unconsolidated entities***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three months ended July 31,**  | **Three months ended July 31,**  | **Three months ended July 31,**  | **Nine months ended July 31,** | **Nine months ended July 31,** | **Nine months ended July 31,** |
|  | **2025** | **Change** | **2024** | **2025** | **Change** | **2024** |
|  | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** | **(Dollars in thousands)** |
| Income (loss) from unconsolidated entities | $(402) | (31)% | $(579) | $178 | (148)% | $(374) |

---

Income (loss) from unconsolidated entities includes our participation in earnings or losses from our investments in Agricola Don Memo. For the three months ended July 31, 2025 and 2024 we realized losses of $0.4 million and $0.6 million from Agricola Don Memo. For the nine months ended July 31, 2025 and 2024 we realized income (loss) of $0.2 million and $(0.4) million from Agricola Don Memo.

***Income tax benefit (expense)***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Three months ended July 31,**  | **Three months ended July 31,**  | **Three months ended July 31,**  | **Nine months ended July 31,**  | **Nine months ended July 31,**  | **Nine months ended July 31,**  |
|  | **2025** | **Change** | **2024** | **2025** | **Change** | **2024** |
| Income tax benefit (expense) | $(1807) | (225)% | $1441 | $(5598) | (1271)% | $478 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effective tax rate | 26% |  | (37)% | 26% |  | (5)% |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The effective tax rates for the three months ended July 31, 2025 and July 31, 2024 were 26% and (37)%. The effective tax rates for the nine months ended July 31, 2025 and July 31, 2024 were 26% and (5)%. The Company's effective tax rate for the three and nine months ended July 31, 2025 differs from the U.S. federal statutory rate of 21% due to the U.S. state tax and foreign tax rate differential in Mexico. The Company's effective tax rate for the three and nine months ended July 31, 2024 differs from the U.S. federal statutory rate of 21% due to valuation allowances on domestic deferred tax assets that were not more likely than not to be realized, and foreign exchange losses in Mexico.

[**Table of Contents**](#Toc)

**Liquidity and Capital Resources** 

Cash provided in operating activities was $19.2 million for the nine months ended July 31, 2025, compared to cash provided by operating activities of $13.6 million for the corresponding period in fiscal 2024. Cash provided in operating activities for the nine months ended July 31, 2025 reflects primarily our net income of $16.1 million, combined with non-cash activities (depreciation and amortization, non-cash operating lease expense, stock-based compensation expense, income from unconsolidated entities, and loss on disposal of property, plant and equipment) of $6.1 million which was partially offset by a net effect of changes in operating assets and liabilities of $3.0 million.

Changes in operating assets and liabilities included a decrease in inventories of $3.8 million, a decrease in prepaid expenses and other current assets of $2.2 million, a net decrease in accounts payable, accrued expenses and other liabilities of $17.0 million, an increase in payable to growers of $13.5 million, and a decrease in income tax payable of $1.0 million, partially offset by a decrease in other assets of $4.7 million.

The decrease in our inventory as of July 31, 2025, compared to October 31, 2024, was primarily due to revaluations of the inventory on hand. The decrease in our prepaid and other current assets is primarily due to an increase in amortization of prepaid expenses, and the timing of rebate receipts. The increase in payable to growers is mostly due to an increase in farming activity of tomatoes as farming production for the spring/summer cycle (May-October) is scaling up.

Cash used in investing activities was $1.1 million for the nine months ended July 31, 2025, compared to cash used by investing activities of $2.5 million for the corresponding period in fiscal 2024. Cash used in investing activities relates principally to purchases of property, plant, and equipment.

Cash used in financing activities was $11.4 million for the nine months ended July 31, 2025, compared to cash used by financing activities of $12.8 million for the corresponding period in fiscal 2024. Cash used in financing activities relates principally to payments of $10.7 million in dividends, payments on long-term obligations of $0.7 million and the payment of minimum withholding of taxes on the net settling of shares of less than $0.1 million.

Our principal sources of liquidity are our existing cash reserves, cash generated from operations, and amounts available for borrowing under our credit facility. Cash and cash equivalents as of July 31, 2025 and October 31, 2024, totaled $63.8 million and $57.0 million. Our working capital at July 31, 2025 was $89.9 million, compared to $85.4 million at October 31, 2024.

We believe that our cash balance, cash flows from operations, availability under our credit facility, and other sources will be sufficient to satisfy our future capital expenditures and commitments, grower recruitment efforts, working capital and other financing requirements for the foreseeable future.

On June 26, 2023, we entered into a credit agreement (the "Credit Agreement") with Wells Fargo Bank, National Association, as agent and lender ("Agent" or "Wells Fargo"). The Credit Agreement provided for a revolving credit facility (the "Revolving Loans") of up to $90.0 million, along with a capex credit facility of up to $10.0 million (the "Term Loan").

On August 15, 2024, we entered into a First Amendment to Credit Agreement and Consent with Wells Fargo whereby (i) the Credit Agreement was amended to reduce the revolving commitments thereunder from $90.0 million to $75.0 million, among other minor adjustments to align the borrowing base with our asset base excluding the Fresh Cut business (which was sold on August 15, 2024); and (ii) we obtained consent from Agent for entry into the Asset Purchase Agreement and Purchase and Sale Agreement with respect to the sale of the Fresh Cut business.

Borrowings of the Revolving Loans under the Credit Agreement are asset based and are subject to a borrowing base calculation that includes a certain percentage of eligible accounts receivable, inventory and equipment, less any reserves implemented by Agent in its permitted discretion, provided that the equipment-based portion of such borrowing base calculation reduces monthly according to scheduled amortization.

[**Table of Contents**](#Toc)

Borrowings under the Credit Agreement bear interest at a rate per annum equal to an applicable margin, plus, at our option, either a base rate or a secured overnight financing rate ("SOFR") term rate (which includes a spread adjustment of 0.10% and is subject to a floor of 0.00%). The applicable margin is (i) for Revolving Loans, 0.50% for base rate borrowings and 1.50% for SOFR term rate borrowings, and (ii) for Term Loan, 1.00% for base rate borrowings and 2.00% for SOFR term rate borrowings. The credit facility matures on June 26, 2028.

As of July 31, 2025, we were in compliance with the financial covenants in the Credit Agreement, as amended. As of July 31, 2025, approximately $50.5 million was available for borrowing, based on our borrowing base calculation discussed above.

The weighted-average interest rate under the credit facility was 8.0% at July 31, 2025. Under the credit facility, there was less than $0.1 million outstanding related to the Revolving Loans and Term Loan as of July 31, 2025.

In March 2025, our Board of Directors authorized a stock repurchase program of up to $25 million. While no shares have been repurchased to date under this program, the timing and volume of repurchases will depend on market conditions, our capital allocation priorities, and other strategic considerations.

**Contractual Commitments**

There have been no other material changes to our contractual commitments from those previously disclosed in our Annual Report on Form 10-K for our fiscal year ended October 31, 2024.

**ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK** 

There have been no material changes in market risk from the information provided in *Item 7A. Quantitative and Qualitative Disclosures About Market Risk* of our Annual Report on Form 10-K for the year ended October 31, 2024.

**ITEM 4. CONTROLS AND PROCEDURES**

As required by Rule 13a-15 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), we carried out an evaluation, under the supervision and with the participation of management, including the Chief Executive Officer (who is our principal executive officer) and Chief Financial Officer (who is our principal financial officer), of the effectiveness of the design and operation of our disclosure controls and procedures as of July 31, 2025. Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of such date to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission rules and forms.

There were no changes in our internal control over financial reporting during the quarter ended July 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**PART II. OTHER INFORMATION**

**ITEM 1. LEGAL PROCEEDINGS**

Please refer to Note 6 to the unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q for information.

[**Table of Contents**](#Toc)

**ITEM 1A. RISK FACTORS**

For a discussion of our risk factors, see Part I, Item 1A "Risk Factors" of our Annual Report on Form 10-K for the year ended October 31, 2024, as supplemented by our Quarterly Report on Form 10-Q for the quarterly period ended January 31, 2025. There have been no material changes from the risk factors set forth in such Annual Report on Form 10-K and Quarterly Report on Form 10-Q. However, the risks and uncertainties that we face are not limited to those set forth in such Annual Report on Form 10-K and Quarterly Report on Form 10-Q. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business and the trading price of our common stock.

[**Table of Contents**](#Toc)

**ITEM 5. OTHER INFORMATION**

***(c) Trading Plans***

During the quarter ended July 31, 2025, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

***Supplemental Cybersecurity Governance and Program Update***

The Company's Board of Directors (the "Board") currently provides direct oversight of cybersecurity risk. The Board is supported by directors with relevant experience in technology governance, cybersecurity oversight, and risk management, including director-level cybersecurity education and certifications.

Our ongoing evaluation against the NIST Cybersecurity Framework 2.0, expected to be completed in our fourth quarter 2025, indicates that our residual risk profile remains within acceptable parameters.

We have launched a systematic program enhancement initiative focused on elevating cybersecurity program maturity through structured documentation, policy refinement, and capability advancement. This twelve-month strategic effort will adapt dynamically to emerging threat landscapes and resource allocation priorities.

**ITEM 6. EXHIBITS**

---

| | |
|:---|:---|
| 31.1 | [Certification of Chief Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](cvgw-20250731xex31d1.htm) |
| 31.2 | [Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](cvgw-20250731xex31d2.htm) |
| 32.1 | [Certification by Chief Executive Officer and Chief Financial Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. \*](cvgw-20250731xex32d1.htm) |
| 101.INS# | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH# | Inline XBRL Schema Document |
| 101.CAL# | Inline XBRL Calculation Linkbase Document |
| 101.DEF# | Inline XBRL Definition Linkbase Document |
| 101.LAB#  | Inline XBRL Labels Linkbase Document |
| 101.PRE# | Inline XBRL Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |

---

\* This certification is not deemed filed for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.

# The following financial information from the Quarterly Report on Form 10-Q of Calavo Growers, Inc. for the quarter ended July 31, 2025, formatted in Inline XBRL (Extensible Business Reporting Language) includes: (1) Consolidated Balance Sheets as of July 31, 2025 and October 31, 2024; (2) Consolidated Statements of Operations for the three and nine months ended July 31, 2025 and 2024; (3) Consolidated Statements of Cash Flows for the three and nine months ended July 31, 2025 and 2024; (4) Consolidated Statements of Shareholders' Equity for the three and nine months ended July 31, 2025 and 2024; (5) Notes to Consolidated Financial Statements; and (6) the information included in Part II, Item 5(c).

[**Table of Contents**](#Toc)

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | Calavo Growers, Inc. | Calavo Growers, Inc. |
|  | (Registrant) | (Registrant) |
| Date: September 9, 2025 |  |  |
|  | By | /s/ Lecil E. Cole |
|  |  | Lecil E. Cole |
|  |  | Chief Executive Officer<br>(Principal Executive Officer)  |
| Date: September 9, 2025 |  |  |
|  | By | /s/ James Snyder |
|  |  | James Snyder |
|  |  | Chief Financial Officer <br>(Principal Financial Officer)  |

---

## Exhibit 31.1

**Exhibit 31.1**

CERTIFICATION PURSUANT TO

15 U.S.C. § 7241

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Lecil E. Cole, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of Calavo Growers, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements and other financial information included in this report, fairly present, in all material respects, the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: September 9, 2025 | /s/ Lecil E. Cole  |
|  | Lecil E. Cole |
|  | Chief Executive Officer (Principal Executive Officer) |

---

------

## Exhibit 31.2

**Exhibit 31.2**

CERTIFICATION PURSUANT TO

15 U.S.C. § 7241

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, James Snyder, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of Calavo Growers, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements and other financial information included in this report, fairly present, in all material respects, the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: September 9, 2025 | /s/ James Snyder  |
|  | James Snyder |
|  | Chief Financial Officer (Principal Financial Officer) |

---

------

## Exhibit 32.1

**Exhibit 32.1**

WRITTEN STATEMENT OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

The undersigned Chief Executive Officer and Chief Financial Officer of Calavo Growers, Inc. (the "Company"), each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Company's Quarterly Report on Form 10-Q for the quarter ended July 31, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), fully complies with the requirements of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| Dated: September 9, 2025 |
| /s/ Lecil E Cole |
| Lecil E. Cole |
| Chief Executive Officer |
| /s/ James Snyder |
| James Snyder |
| Chief Financial Officer |

---

------